Related references
Note: Only part of the references are listed.Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis
Joost Smolders et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis
K. Claire Simon et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production
Bryan R. Becklund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Clinical implications of a possible role of vitamin D in multiple sclerosis
Charles Pierrot-Deseilligny
JOURNAL OF NEUROLOGY (2009)
Vitamin D treatment in multiple sclerosis
Kjell-Morten Myhr
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Genetics and pathogenesis of multiple sclerosis
R. L. Zuvich et al.
SEMINARS IN IMMUNOLOGY (2009)
Vitamin D as an immune modulator in multiple sclerosis, a review
Joost Smolders et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Pathophysiology of multiple sclerosis
Thomas Korn
JOURNAL OF NEUROLOGY (2008)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J. Smolders et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Epidemiology of multiple sclerosis: From risk factors to prevention
Alberto Ascherio et al.
SEMINARS IN NEUROLOGY (2008)
The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude
Ingrid A. F. van der Mei et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2007)
Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis
Suhayl Dhib-Jalbut
NEUROLOGY (2007)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Vitamin D and cancer
Roger Bouillon et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
1,25 dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis
Gladson Muthian et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis
DM Wingerchuk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Vitamin D deficiency and reduced bone mineral density in multiple sclerosis:: effect of ambulatory status and functional capacity
S Ozgocmen et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2005)
25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis
M Soilu-Hänninen et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Cytokines in multiple sclerosis: from bench to bedside
J Imitola et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Vitamin D intake and incidence of multiple sclerosis
KL Munger et al.
NEUROLOGY (2004)
Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone
E Van Etten et al.
BONE (2003)
Cytokine profile in patients with multiple sclerosis following vitamin D supplementation
BD Mahon et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis
FE Nashold et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation
IAF van der Mei et al.
NEUROEPIDEMIOLOGY (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production
CM Pelfrey et al.
JOURNAL OF IMMUNOLOGY (2000)
Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system
CM Veldman et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients
I Nordvik et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
1,25-dihydroxyvitamin D-3 treatment decreases macrophage accumulation in the CNS elf mice with experimental autoimmune encephalomyelitis
FE Nashold et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
